Here’s a breakdown of the information provided, formatted for clarity:
Research Publications:
* Neuen BL, et al. SGLT2 Inhibitors and Kidney Outcomes and Glomerular Filtration Rate and Albuminuria, JAMA (2025).
* DOI: 10.1001/jama.2025.20834
* Staplin N, et al. absolute effects of sodium glucose co-transporter-2 inhibitors by diabetes status and level of albuminuria: A SMART-C meta-analysis. JAMA. (2025).
* DOI: doi.org/10.1001/jama.2025.20835
Source:
* Provided by: George Institute for Global Health (https://medicalxpress.com/partners/george-institute-for-global-health/)
* George Institute website: http://www.georgeinstitute.org/
Citation (for print):
* Routine use of metabolic drug recommended for all kidney function levels (2025, November 7)
